Detection and management of an implantable cardioverter defibrillator lead failure: Incidence and clinical implications

Journal of the American College of Cardiology

Volumn 41, Issue 1, 2003, Pages 73-80

  Ellenbogen, Kenneth A ^a   Wood, Mark A ^a   Shepard, Richard K ^a   Clemo, Henry F ^a   Vaughn, Tim ^b   Holloman, Keith ^b   Dow, Marlene ^b   Leffler, Jeanne ^a   Abeyratne, Athula ^b   Verness, Dave ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDTRONIC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE; FEMALE; FOLLOW UP; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELIABILITY; RR INTERVAL; SURVIVAL;

AGED; DEFIBRILLATORS, IMPLANTABLE; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; EQUIPMENT FAILURE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYURETHANES; PREDICTIVE VALUE OF TESTS; TACHYCARDIA, VENTRICULAR; TIME FACTORS;

EID: 0037219077     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02620-7     Document Type: Article

References (24)

1. Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines for implantation of cardiac pacemakers, and antiarrhythmic devices: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 1998;97:1325-35.
2. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
3. Stambler BS, Wood MA, Damiano RJ, Greenway PS, Smutka ML, Ellenbogen KA. Sensing/pacing lead complications with a newer generation implantable cardioverter-defibrillator: A worldwide experience from the Guardian ATP 4210 clinical trial. J Am Coll Cardiol 1994;23:123-32.
4. Schwartzman D, Nallamothu N, Callans DJ, Preminger MW, Gottlieb CD, Marchlinski FE. Postoperative lead-related complications in patients with nonthoractomy defibrillation lead systems. J Am Coll Cardiol 1995;25:776-86.
5. Gahy GJ, Kleman JM, Wilkoff BL, Morant VA, Pinski SL. Low incidence of lead related complications associated with non-thoracotomy implantable cardioverter defibrillator systems. Pacing Clin Electrophysiol 1995;18:172-8.
6. Lawton JS, Ellenbogen KA, Wood MA, et al. Sensing lead-related complications in patients with transvenous implantable cardioverter-defibrillators. Am J Cardiol 1996;78:647-51.
7. Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with pectoral implantation of cardioverter defibrillators: World-wide jewel investigators. Pacing Clin Electrophysiol 1997;20:208-11.
8. Degertu FT, Khalighi K, Peters RW, Shorofsky SR, Gold MR. Sensing lead failure in implantable defibrillators: A comparison of two commonly used leads. J Cardiovasc Electrophysiol 2000;11:21-4.
9. Tyers GF, Sanders R, Jacqmein W. Reliability of coated wire defibrillation leads. Pacing Clin Electrophysiol 1999;22:174-8.
10. Luria D, Glikson M, Brady PA, et al. Predictors and mode of detection of transvenous lead malfunction in implantable defibrillators. Am J Cardiol 2001;87:901-4.
11. Kron J, Herre J, Renfroe EG, et al. Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial. Am Heart J 2001;141:92-8.
12. Mehta D, Nayak HM, Singson M, et al. Late complications in patients with pectoral defibrillator implants with transvenous defibrillator lead systems: High incidence of insulation breakdown. Pacing Clin Electrophysiol 1998;21:1893-900.
13. Lawton JS, Wood MA, Gilligan DM, Stambler BS, Damiano RJ Jr., Ellenbogen KA. Implantable transvenous cardioverter defibrillator leads: The dark side. Pacing Clin Electrophysiol 1996;19:1273-8.
14. Korte T, Jung W, Spehl S, et al. Incidence of ICD lead related complications during long-term follow-up: Comparison of epicardial and endocardial electrode systems. Pacing Clin Electrophysiol 1995;18:2053-61.
15. Bracke FALE, Meijer A, van Gelder LM. Malfunction of endocardial defibrillator leads and lead extraction: Where do they meet? Europace 2002;4:19-24.
16. Bardy GH, Yee R, Jung W. Multicenter experience with a pectoral implantable cardioverter-defibrillator: Active Canadian investigators. J Am Coll Cardiol 1996;28:400-10.
17. Roelke M, O'Nunain SS, Osswald S, Garan H, Harthorne JW, Ruskin JN. Subclavian crush syndrome complicadng transvenous cardioverter defibrillator systems. Pacing Clin Electrophysiol 1995;18:973-9.
18. Hauser RG, Cannom D, Hayes DL, et al. Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol 2002;25:879-82.
19. Gunderson B, Wood N, Pearson A, Wang W, Olson W. A new sensing integrity indicator for ventricular pace/sense leads. Pacing Clin Electrophysiol 2000;23:591.
20. Medtronic Inc. ICD Lead Survival Analysis. Tachyarrhythmia Product Performance Report. 2nd Ed. Fridley, MN: Medtronic, 2001.
21. Hayes DL, Graham KJ, Irwin M, et al. Multicenter experience with a bipolar tined polyurethane ventricular lead. Pacing Clin Electrophysiol 1995;18:999-1004.
22. Antonelli D, Rosenfeld T, Freedberg NA, Palma E, Gross JN, Furman S. Insulation lead malfunction: Is it a matter of insulation coating, venous approach, or both? Pacing Clin Electrophysiol 1998;21:418-21.
23. Mond HG. Engineering and clinical aspects of pacing leads. In: Ellenbogen KA, Kay GN, Wilkoff BL, editors. Clinical Cardiac Pacing and Defibrillation. Philadelphia, PA: WB Saunders Company, 2000:127-50.
24. Bardy GH, Cappato R, Smith WM, et al. The totally subcutaneous ICD system (the S-ICD) (abstr). Pacing Clin Electrophysiol 2002;24:578.